Rozanolixizumab
Definition: Rozanolixizumab, sold under the brand name Rystiggo, is a monoclonal antibody used for the treatment of myasthenia gravis. Rozanolixizumab is a humanized and chimeric monoclonal antibody; and is a neonatal Fc receptor blocker. source: Wikipedia
- ID
- 42755511000001109
- Name
- Rozanolixizumab